Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonic bacteria, also known as the colonic microbiota or gut flora of the colon, are a diverse community of microorganisms—primarily bacteria—that inhabit the large intestine (colon) in humans and other animals. These bacteria are mostly anaerobic, thriving in the low-oxygen environment of the colon. They play essential roles in digestion, metabolism, immune function, and maintaining overall gut health. Key functions include fermentation of undigested carbohydrates, nutrient synthesis (e.g., vitamins), and immune modulation. Disruption or imbalance (dysbiosis) can lead to increased susceptibility to infections and various diseases.
N/A (Complex Community - Mechanisms Vary Widely Depending on Specific Bacteria)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic Bacteria.